Zyphar's Pharmaceutics Private Limited - Company Profile

It is a pharma private limited company based in Pune, Maharashtra, India, established in 2006.
2006 Pune, Maharashtra, India Active
Last Updated:
Access Report
About Zyphar's Pharmaceutics Private Limited

Zyphar's Pharmaceutics Private Limited, a active private limited company, was established on 17 February 2006 in Pune, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231PN2006PTC022042. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.95 Cr and a paid-up capital of ₹4.95 Cr.

It upholds a compliant status. Employing 146 professional, Its leadership includes Mahendra Champalal Jain (Director), Rajeshkumar Champalal Jain (Managing Director), Roshan Champalal Jain (Director). Past directors included Rajeshkumar Champalal Jain, Sachin Ganeshmal Sonigara. It holds ₹20.75 Cr open charges and ₹6.89 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231PN2006PTC022042

  • Registration Number

    022042

  • Incorporation Date

    17 February 2006

  • Authorized Capital

    ₹4.95 Cr

  • Paid-Up Capital

    ₹4.95 Cr

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.95 Cr
  • Paid Up Capital ₹ 4.95 Cr
  • Company Age 20 Year, 27 Days
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.75 Cr
  • Satisfied Charges ₹ 6.89 Cr
  • Revenue Growth **** -8.71%
  • Profit Growth **** 15.54%
  • Ebitda **** 62.14%
  • Net Worth 29.53%
  • Total Assets **** 5.35%
Company report

Zyphar's Pharmaceutics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Zyphar's Pharmaceutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Zyphar's Pharmaceutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Mahendra Champalal Jain Director 17 Feb 2006 Current
Rajeshkumar Champalal Jain Managing Director 17 Feb 2006 Current
Roshan Champalal Jain Director 17 Feb 2006 Current
Kapil Ganeshmal Sonigara Director 17 Feb 2006 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Jan 2014 Past
Pramod Abcsdd Director 09 Jan 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Zyphar'S Pharmaceutics.

Zyphar'S Pharmaceutics Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 8.71% decrease. The company also saw a substantial improvement in profitability, with a 15.54% increase in profit. The company's net worth Soared by an impressive increase of 29.53%.

Zyphar'S Pharmaceutics revenue growth over time
Zyphar'S Pharmaceutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -8.71%
*******
*******
*******
*******
Revenue from Operations
*******
 -6.24%
*******
*******
*******
*******
Total Assets
*******
 5.35%
*******
*******
*******
*******
Profit or Loss
*******
 15.54%
*******
*******
*******
*******
Net Worth
*******
 29.53%
*******
*******
*******
*******
EBITDA
*******
 62.14%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Zyphar'S Pharmaceutics?

In 2024, Zyphar'S Pharmaceutics had a promoter holding of 57.74% and a public holding of 42.26%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹207,500,000.00

Satisfied Charges

₹68,915,000.00

Charges Breakdown by Lending Institutions
  • Others : 20.75 Cr
Latest Charge Details
Date Lender Amount Status
12 Sep 2025 Others ₹2.00 Cr Open
22 Oct 2019 Others ₹1.00 Cr Open
11 Jun 2019 Others ₹1.00 Cr Open
06 Feb 2018 Others ₹5.00 M Open
10 Jun 2016 Others ₹2.50 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Zyphar'S Pharmaceutics?

Zyphar'S Pharmaceutics has a workforce of 146 employees as of Apr 08, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Zyphar'S Pharmaceutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zyphar'S Pharmaceutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Zyphar'S Pharmaceutics
Recent Activity within the Organization
  • Charges

    A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101161431 was registered on 12 Sep 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 16.00 Cr registered on 23 Dec 2014 with Charge ID 10543756 was modified on 12 Sep 2025. was documented.

  • Charges

    Progress on A charge registered on 17 Jun 2021 via Charge ID 100486862 with Others was fully satisfied on 31 Jan 2025. was documented.

  • Charges

    The activity A charge registered on 17 Jun 2021 via Charge ID 100464570 with Others was fully satisfied on 31 Jan 2025. was completed.

  • Annual General Meeting

    Zyphar'S Pharmaceutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Zyphar'S Pharmaceutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Zyphar's Pharmaceutics Private Limited?

The CIN of Zyphar's Pharmaceutics Private Limited is U24231PN2006PTC022042.

Where is Zyphar's Pharmaceutics Private Limited headquartered?

Zyphar's Pharmaceutics Private Limited is headquartered at Office No. 102 & 103, Park Plaza, First Floor, Opp Kamala Nehru Park, Erandwane,, Pune, Maharashtra, 411004.

When was Zyphar's Pharmaceutics Private Limited incorporated?

Zyphar's Pharmaceutics Private Limited was incorporated on 17 February 2006.

Who are the current directors of Zyphar's Pharmaceutics Private Limited?

The current directors of Zyphar's Pharmaceutics Private Limited are

What is the primary industry of Zyphar's Pharmaceutics Private Limited?

The primary industry of Zyphar's Pharmaceutics Private Limited is Trade.

Is Zyphar's Pharmaceutics Private Limited a listed company?

Zyphar's Pharmaceutics Private Limited is unlisted.

What is the capital structure of Zyphar's Pharmaceutics Private Limited?

The authorized capital of Zyphar's Pharmaceutics Private Limited is ₹4.95 Cr, and the paid-up capital is ₹4.95 Cr.

What is the compliance status of Zyphar's Pharmaceutics Private Limited?

The compliance status of Zyphar's Pharmaceutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available